Quantcast
Last updated on April 18, 2014 at 0:00 EDT

Latest Tricuspid valve Stories

2014-01-27 14:46:56

Operation holds promise for patients with infective endocarditis A potentially fatal bacterial disease of the heart, infective endocarditis frequently affects the heart's tricuspid valve, often resulting in permanent tissue damage. But a reconstructive technique, in which the valve is repaired with a bioscaffold on which new tissue can grow, can give some patients a new lease on life—a lease that has been extended to patients at Temple University Hospital, in Philadelphia, thanks to the...

2012-01-18 19:46:55

An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valves, which are complex structures that allow blood to flow from the heart's upper right chamber to the ventricle. If left untreated, severe leakage can affect an individual's quality of life and can even lead to death. A new study finds that the anatomy of the heart's tricuspid valve can be used to predict the severity of leakage in the valve, which is a condition called tricuspid regurgitation....

75da28fbfb354e1abff3b9a5a0a2a68c
2011-08-09 09:28:50

A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition. An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valve, a complex structure that closes off the heart's right ventricle from the right atrium. Most people have at least some leakage in the valve, but what causes the problem is not well understood. A new study, published online in the journal...

2011-06-17 12:57:00

INDIANAPOLIS, June 17, 2011 /PRNewswire/ -- The St. Francis Heart Center today (June 17, 2011) announced that it has performed the first post-FDA approval surgery in the United States using a new device for treating tricuspid valve disease. Called the Contour 3D(TM) Annuloplasty Ring, the device, which is manufactured by Medtronic, is designed to restore normal valve function by remodeling the natural valve's shape and size. The procedure was performed by Marc Gerdisch, M.D., chief...

2010-09-13 12:20:55

David H. Adams, MD, Marie-Jos©e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, has performed the first implantation of the Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring in the United States. Dr. Adams invented the ring, which was recently approved by the Food and Drug Administration. The tricuspid valve lies between the right atrium and right ventricle of the heart. Tricuspid valve regurgitation...

2010-05-27 14:59:12

A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart, according to researchers at Henry Ford Hospital's Heart and Vascular Institute. "Very little has been published regarding the ability of continuous flow pumps to have similar effects on the right ventricle," says study lead author Jeffrey Morgan, M.D., director of Cardiac Surgery Research...

2008-09-10 12:00:51

MiCardia, which develops implantable devices for the treatment of heart disease, has announced that the FDA has granted 510(k) marketing clearance for its Dynaplasty Annuloplasty Band DR and Annuloplasty Ring DR. These are said to be MiCardia's first Dynaplasty technology products to receive clearance. MiCardia is developing the Dynaplasty technology for the percutaneous and non-invasive treatment of structural heart disease including mitral valve regurgitation, tricuspid valve...